DOTMA:DOPE (50:50) Liposomes (CAT#: LDLY-0123-LY193)

Description
Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy.
Lipid Composition
DOTAM: 50M
DOPE:50M
Applications
Cancer research; Target delivery
Hydration Solution
Deionized RNAse-free Water
External Solution
Deionized RNAse-free Water
Storage
2°C - 8°C in dark (do not freeze)
Size
100 nm
Shelf Life
6 months
Quantity
5mL (available in lyophilized powder)
Download
DataSheet MSDS
FAQs Published Data Customer Reviews Related Sections
  1. What defines the composition and purpose of DOTMA:DOPE (50:50) liposomes?

    DOTMA:DOPE (50:50) liposomes consist of an equal molar mixture of DOTMA, a cationic lipid, and DOPE, a neutral helper lipid. This composition is specifically designed to enhance the delivery of nucleic acids, such as DNA and RNA, into cells by neutralizing the negative charge of the nucleic acids through electrostatic interactions, thereby facilitating their cellular uptake.

  2. What is the optimal method for loading nucleic acids into DOTMA:DOPE liposomes?

    Nucleic acids can be efficiently loaded into DOTMA:DOPE liposomes through a process known as complexation, where the negatively charged nucleic acids interact electrostatically with the positively charged liposomes. This process is usually performed at room temperature, with careful titration of nucleic acid to achieve the desired charge ratio.

  3. What are the implications of DOTMA:DOPE liposomes' pH sensitivity for gene delivery?

    The pH sensitivity of DOTMA:DOPE liposomes is crucial for their gene delivery capabilities. Upon encountering the acidic environment inside endosomes, these liposomes undergo a pH-dependent conformational change that promotes endosomal membrane destabilization and subsequent release of their genetic cargo into the cytoplasm, which is a critical step for successful gene expression​.

  4. What is the significance of membrane fusion in the function of DOTMA:DOPE liposomes?

    Membrane fusion is a key mechanism through which DOTMA:DOPE liposomes deliver their cargo into cells. After endocytosis, the fusogenic property of DOPE facilitates the fusion of liposomes with endosomal membranes, leading to the release of the encapsulated nucleic acids into the cytoplasm, where they can exert their biological effects.

  5. How do you measure the transfection efficiency of DOTMA:DOPE liposomes?

    The transfection efficiency of DOTMA:DOPE liposomes can be evaluated using a reporter gene assay, such as luciferase or GFP, where the expression level of the reporter gene in the target cells indicates the success of nucleic acid delivery. Quantitative PCR and flow cytometry are also commonly used methods to assess transfection efficiency.

DOTMA:DOPE (50:50) Liposomes-fig1


Tumour uptake of formulations following intravenous administration

The research explores the novel application of DOTMA:DOPE (50:50) liposomes for targeted genetic therapy, specifically focusing on neuroblastoma. Through sophisticated engineering of cationic nanovesicle complexes derived from giant unilamellar vesicle (GUV) precursors, this study benchmarks a new stride in genetic therapy delivery systems. Incorporating both plasmid DNA or siRNA and targeting peptide ligands, the engineered nanovesicles demonstrated promising biocompatibility in vitro and in vivo, without the cytotoxicity or significant immune activation typically associated with cationic liposome-based systems. Unlike their lipopolyplex counterparts, these nanovesicles showed no substantial cytotoxicity or complement system activation, making them a safer option for intravenous administration and tumor therapy.

Tagalakis, A. D., Maeshima, R., et al. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: targetable nanocomplexes for in vivo nucleic acid delivery. Acta biomaterialia. 2017, 51: 351-362.

  • Unmatched Efficiency in Gene Delivery
    Creative Biolabs' DOTMA:DOPE liposomes exhibit unparalleled efficacy in the delivery of genetic materials. Their superior electrostatic interaction capabilities significantly enhance plasmid capture and delivery.
  • Enhanced Payload Capacity
    These liposomes have revolutionized our approach to nucleic acid delivery. The unique DOTMA:DOPE ratio significantly increases payload capacity, offering new possibilities in gene therapy.
  • Benchmark in Transfection Efficiency
    Creative Biolabs has set a new benchmark with their DOTMA:DOPE (50:50) liposomes. Their exceptional transfection efficiency has propelled our research forward.
  • Pioneering Drug Delivery Solution
    Creative Biolabs' expertise in liposome technology is evident in their DOTMA:DOPE product. Its innovative design has made it a pivotal tool in our drug delivery research.

Click the button below to contact us or submit your feedback about this product.

For Research Use Only. Not For Clinical Use

Online Inquiry